Ledger.Open graph →
SEC Form D · filed November 7, 2014

Erytech Pharma

Offering
—
Sold
$37.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LYON, I0
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Yann Godfrin · LYON, I0DirectorPierre-Olivier Goineau · LYON, I0DirectorGil Beyen · LYON, I0ExecNeil A. Cox · LONGMONT, CODirectorJoseph J. Scaravilli · Beachwood, OHDirectorBryan Garnier & Co · LONDON, United KingdomPromoterJ?R?Me Bailly · CHASSIEU, I0DirectorLifeSci Capital · NEW YORK, NYPromoterMichael A. Willis · BOULDER, COExec · DirectorWilliam A. Kent · BOULDER, CODirectorZung V. Tran · ERIE, COExecBryan Garnier & Co · LONDON, United KingdomPromoterJ?R?Me Bailly · CHASSIEU, I0DirectorLifeSci Capital · NEW YORK, NYPromoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗